Trials / Unknown
UnknownNCT03155971
PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)
Efficacy and Safety of Paclitaxel-Coated Balloon Catheter in Patients With Long De Novo Lesions of Main Coronary Arteries
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- The People's Hospital of Liaoning Province · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the Efficacy and Safety of Paclitaxel-Coated Balloon Catheter in Patients With Diffuse Long De Novo Lesions of Main Coronary Arteries.
Detailed description
Paclitaxel-Coated Balloon Catheter is a new device in coronary disease, it can inhibit the proliferation of smooth muscle of coronary vessels by transitory contaction, without residual implantation. More and more evidences have shown its efficacy and safety in diffuse small coronary disease, bifurcation disease and in-stent restenosis. But there are still seldom evidences in De Novo Lesions of Main Coronary Arteries. PCB has used in some subgroup of many study but confused with in-stent renstenosis or small coronary disease. The investigators designed this study to evaluate the Efficacy and Safety of Paclitaxel-Coated Balloon Catheter in Patients With Diffuse Long De Novo Lesions of Main Coronary Arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Paclitaxel-Coated Balloon | SeQuent ® Please; B.Braun, Melsungen, Germany |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2019-01-01
- Completion
- 2019-02-01
- First posted
- 2017-05-16
- Last updated
- 2017-05-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03155971. Inclusion in this directory is not an endorsement.